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A B S T R A C T The response of uteroplacental blood flow (UBF) to angiotensin II is controversial. Moreover, the relationship of the uterine and systemic responses to infused angiotensin II is not well understood. Thus, in eight chronically instrumented, near-term pregnant sheep, we have determined the relationships between the dose and duration of constant systemic infusions of angiotensin II ([Val5] ANG II) and changes in UBF, uterine vascular resistance (UVR), mean arterial pressure (MAP), and systemic vascular resistance (SVR).
[Val5] ANG II caused dose-dependent increases in UVR and MAP at all doses studied (P < 0.05). The response in UBF was bidirectional, with increases at doses s1. 15 Ag/min and decreases at .2.29 ug/min (P < 0.05). Increases in UBF occurred when the relative rise (A) in MAP > A UVR, whereas UBF was unchanged when A MAP = A UVR and decreased when A MAP < A UVR. SVR also rose in a dose-dependent fashion (P < 0.05); A SVR was >A UVR at doses . Received for publication 8 September 1980 and in revised form 17 April 1981.
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conflicting results. There have been reports of both decreases (1) (2) (3) and increases (4) (5) (6) (7) (8) (9) (10) (11) in uteroplacental blood flow (UBF).1 This has resulted in the conflicting conclusions that angiotensin II acts either as a uterine vasoconstrictor, as in other vascular beds, or as if it has a paradoxical and "unique" vasodilator action on the uterine vasculature (5). This is an important issue in view ofevidence that renin is produced in the pregnant uterus of several species including the human (12) , and that in the pregnant rabbit, uterine renin release is increased under conditions of uterine hypoperfusion (5) . If indeed angiotensin II has a selective vasodilator action on the pregnant uterus while increasing constriction of nonuterine vessels of the systemic circulation, a potent mechanism is implied by which a fall in uteroplacental perfusion could result in a selective, compensatory rise in UBF by means of a rise in circulating angiotensin II. Moreover, this would suggest a mechanism for the autoregulation of UBF through the release of uterine renin.
We have recently reported (13) The ewes were maintained after operationi in individual stalls kept in the laboratory. They were given standard animal chow (Ralston Purina Co., St. Louis, Mo.) and water ad lii. throughout the study period. Body weight remained constant or increased. The animals were studied only after they were considered to have recovered from surgical trauma and anesthesia, as evidenced by a normal response of uterine blood flow to 1 ,ug/kg of intravenous 17,8-estradiol (15, 16) .
No animal was stLdied until at least day 6 after surgery. Two studies were carried out on each animal 2-6 d apart.
[Val15ANG II (Ciba-Geigy Corp., Summit, N. J.) was diluted in sterile isotonic saline to a concenitration of 3 In five animals cardiac output was measured by the dyedilution technique. 5 mg of indocyanine green (Hynson, Wescott and Dunning, Inc., Baltimore, Md.) was injected rapidly into the inferior vena cava via one indwelling catheter while blood was withdrawn at 10 ml/min through a densitometer from a femoral arterial catheter. This blood was later reinfused into the animal. Optical density was recorded graphically and cardiac output calculated by electronic integration directly from the signal. The results of cardiac output calculated electronically by this equipment (Waters Instruments, Inc., Rochester, Minn.) were compared with results obtained from the measurement of the area under the curve of the graphic recording. Mean values for repeated measures by the two methods were within 2% of each other, and variability about the mean was the same. Therefore, the value obtained by electronic integration has been used in this report. All measurements were carried out in duplicate and the average taken.
As increases in UBF may be produced by either uterine vasodilation or an increase in uterine perfusion pressure, we have calculated uterine vascular resistance (UVR) in these studies. This allows for the effect of increased perfusion pressure in examining the action of [Val'] ANG II on the uterine vasculature. Uterine vascular resistance may be calculated as the difference between mean arterial and venous pressures, divided by uterine blood flow. Uterine and systemic venous pressures were measured during the experiments in several animals and both were found to be consistently low: (Fig. 4) . When the changes in SVR were compared with the simultaneous changes in UVR, the response in SVR exceeded that of UVR at 0.573, 1 Effect of duration of infusion. As pointed out earlier, UBF has been noted to increase shortly after the initiation of a systemic infusion of a high dose of [Val5] ANG II, only to fall after the 1st min and to attain a steady state by 5 min, at which time a decrease in UBF has occurred (Fig. 1) . In view of this observation we sought to determine the relationship of the changes in UBF, MAP, and UVR during the systemic infusion of FIGURE 5 The simultaneous changes in UBF (A), MAP Fig. 5A . These responses can be explained by examining the simultaneous changes in MAP and UVR. The changes that occurred in MAP and UVR were dose related ( Fig. 5B and C) . However, when one compares the changes in MAP with those of UVR, there is a distinct difference in the rapidity of the responses, MAP reaching >80% ofthe final response by 1.4 min, whereas 80% of the final response in UVR is not attained until 2.8 min or later. This difference provides an explanation for the biphasic changes in UBF illustrated in Figs. 1 and 5A. For example, at 11.5 Mg [Val5] ANG II/min, the peak in UBF occurs at a time, -0.75 min, when a relatively large increase in MAP, 44%, is offset by only a small increase in UVR, 13%. Subsequently, MAP rises only slightly whereas UVR continues to increase, and UBF is found to fall. Eventually, at -2 min, the rise in UVR becomes equivalent to the increase in MAP (59%) and no net change in UBF is observed; after this the continuing rise in UVR outweighs the change in MAP, resulting in the net fall in UBF seen during the steady state. This pattern of a delay in the rise in UVR compared with that in MAP was seen at all doses examined. DISCUSSION It has not been clear whether the changes in uterine blood flow produced by infused angiotensin TI in various species were reflective of uterine vasoconstriction or vasodilation. Part of this dilemma could have resulted from the use of animals studied during the stress of surgery and anesthesia as pointed out specifically with regard to angiotensin II by Assali et al. (14) and other vasoactive compounds by Killam et al. (15) and Rosenfeld et al. (16) . However, in studies using chronically instrumented pregnant ewes remote from surgery, we (13) and Lieb et al. (20) (Fig. 5) . That is, whenever the rise in perfusion pressure exceeded that in UVR, there was a net increase in UBF, and when the rise in UVR exceeded that in MAP, a net decrease in UBF resulted. This relationship has been noted recently by others (20) . However, in many ofthe previous studies of the effect of angiotensin II on UBF, in which UVR was not carefully evaluated, it has been concluded that the rise in UBF was a reflection of uterine vasodilation. We would argue that in the situation where perfusion pressure is changing, the existence of vasoconstriction vs. vasodilation in any organ bed is more appropriately determined by considering the changes in vascular resistance rather than those in absolute blood flow. It is likely that if this principle were applied to previously published data, conclusions similar to those made in our study might be drawn. Additionally, it can be seen 472 in arterial pressure, can result in increased uteroplacental perfusion, suggesting a protective mechanism whereby fetal well-being is maintained. A situation analogous to this may exist in women with mild pregnancy-induced hypertension in whom the estimated UBF has been reported to be either normal (23) or increased (24) . In this instance fetal jeopardy and growth retardation are uncommon. However, more severe degrees of systemic vasoconstriction associated with marked pregnancy-induced hypertension are generally considered to be associated with impaired UBF (25 
